Studio comparativo, randomizzato sull’efficacia antinfiammatoria e rigenerativa di un nuovo Dispositivo Medico (DM) a base di Peptidi di Collagene idrolizzato in pazienti con conflitto femoro-acetabolare sottoposti ad artroscopia d’anca

Title

Code

FAI_DM

Type

Sperimentale

Start Year

2021

Status

Terminato

Principal Investigator

+39-051-6366122

enrico.tassinari@ior.it

Tassinari Enrico, MD

2nd Orthopaedic and Traumatologic Clinic

Operational unit that carry out the study

complex unit

Clinica Ortopedica e Traumatologica II

Director

Zaffagnini Stefano, MD

Go to the details >>

Documents and Videos attachament

Attachment

Nulla osta alla conduzione dello studio prot. FAI_DM

Wednesday 10 August 2022, 11:39

PG0008268_2021_ FAI_DM.pdf

You might also be interested in

Clinical Trial

A Phase 2/3, Randomized, Multicenter Study to Evaluate AL102 in Patients with Progressing Desmoid Tumors

Clinical Trial

Phase study 1/2 to evaluate palbociclib (IBRANCE®) in combination with irinotecan and temozolomide or in combination with topotecan and cyclophosphamide in pediatric patients with recurrent orrefractory solid tumors

Sito Web Istituto Ortopedico Rizzoli

DIPARTIMENTO RIZZOLI-SICILIA

Studio comparativo, randomizzato sull’efficacia antinfiammatoria e rigenerativa di un nuovo Dispositivo Medico (DM) a base di Peptidi di Collagene idrolizzato in pazienti con conflitto femoro-acetabolare sottoposti ad artroscopia d’anca

Principal Investigator

Operational unit that carry out the study

Documents and Videos attachament

You might also be interested in